Servier accomplished its acquisition of Day One Biopharmaceuticals and its buyout of Edgewise Therapeutics’ neuromuscular enterprise is predicted to shut later this yr. On the BIO Worldwide Conference, Servier’s high enterprise growth govt defined the rationale for these offers and the way they match the corporate’s general technique.
The submit Servier Government: ‘We Are Not On the lookout for Blockbusters, We’re On the lookout for Progressive Science’ appeared first on MedCity Information.
